by University of North Carolina at Chapel Hill Credit: Pixabay/CC0 Public Domain Vaccination offers long-lasting protection from the worst outcomes of COVID-19, according to a new study by the University of North Carolina at Chapel Hill. The emergence of the delta and omicron variants has raised questions about whether breakthrough infections are caused by waning immunity or...
EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY (EULAR) COVID-19 is the disease caused by infection with the SARS-CoV-2 virus. Since it emerged at the end of 2019, the virus has caused a global pandemic. In February 2021, EULAR, the European Alliance of Associations for Rheumatology, launched COVAX – a physician-reported registry to collect information about COVID...
by University of New South Wales Dr. Deborah Burnett, first author of the paper and Conjoint Senior Lecturer at UNSW’s St Vincent’s Clinical School. Credit: Garvan Institute of Medical Research Medical researchers have outlined a strategy to generate future-proofed COVID-19 vaccines that can resist emergent new viral strains. A study led by the Garvan Institute...
UNIVERSITY OF CALIFORNIA – SAN DIEGO Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria. The new fridge-free COVID-19 vaccines are still in the early stage of development. In mice, the vaccine candidates triggered high production of neutralizing...
Cristina Spanò for NPR With all the talk about COVID-19 vaccines and boosters, it’s easy to forget that there’s another respiratory virus poised to strike. Yes, it’s that familiar winter nemesis, the flu. And there are vaccines to help ward it off — but also misinformation and fears circulating. “We’ve been concerned about vaccine fatigue...
The boosters will be available to individuals eight months after the completion of their second dose. Federal health authorities first announced in mid-August that they would allow immunocompromised people to get special, additional doses of the Moderna and Pfizer/BioNTech vaccines. “IT’S ALMOST CERTAIN THAT MOST PEOPLE WILL EVENTUALLY NEED TO GET BOOSTER SHOTS OR ADDITIONAL DOSES OF THE VACCINES.”...
By Claudia López Lloreda July 19, 2021 Volume 0%00:0901:35 Katalin Karikó of BioNTech speaks at the STAT Breakthrough Science Summit. In the span of the Covid-19 pandemic, and thanks to the success of two of the currently available vaccines for SARS-CoV-2, messenger RNA, or mRNA, went from being an obscure cell biology concept understood and mentioned only...
THE MOUNT SINAI HOSPITAL / MOUNT SINAI SCHOOL OF MEDICINE New York, NY (June 28, 2021) – Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines–in some cases, no detectable response–pointing to the need for antibody testing and precautions for these patients after vaccination, according to...
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO SAN ANTONIO (June 30, 2021) — In a U.S. and Swiss study, nearly all patients with cancer developed a good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients...
Michele Cohen Marill June 23, 2021 The US Food and Drug Administration (FDA) is adding a warning to the fact sheets for the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines as medical experts continue to investigate cases of heart inflammation, which are rare but are more likely to occur in young men and teen boys. Doran Fink, MD, Ph.D.,...
